LISATA THERAPEUTICS, INC. - LSTA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$5.727M
QoQ value delta ($000)
+$4.379M (+324.85%)
Implied price effect (QoQ)
+130.77%
Shares
Total shares
1,316,436
QoQ shares delta
+601,367 (+84.1%)
Total shares held by funds (by quarter)

Market chart (LSTA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 34 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD CAPITAL MANAGEMENT LLC 1,361 271,815 0.0%
RENAISSANCE TECHNOLOGIES LLC 659 131,715 0.0%
VANGUARD GROUP INC 503 270,909 0.0%
DELTEC ASSET MANAGEMENT LLC 450 90,000 0.08%
Rangeley Capital, LLC 375 75,000 0.36%
GEODE CAPITAL MANAGEMENT, LLC 355 70,887 0.0%
CSS LLC/IL 310 61,898 0.01%
BlackRock, Inc. 274 54,857 0.0%
PenderFund Capital Management Ltd. 237 47,500 0.04%
Virtu Financial LLC 211 42,213 0.01%
VANGUARD FIDUCIARY TRUST CO 174 34,917 0.0%
GTS SECURITIES LLC 157 31,396 0.01%
STATE STREET CORP 126 25,348 0.0%
CITADEL ADVISORS LLC 113 22,666 0.0%
JBF Capital, Inc. 66 13,234 0.01%
Cerity Partners LLC 61 12,183 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 58 11,604 0.0%
BANK OF AMERICA CORP /DE/ 51 10,353 0.0%
NORTHERN TRUST CORP 51 10,268 0.0%
HighTower Advisors, LLC 50 10,042 0.0%
ROYAL BANK OF CANADA 29 5,912 0.0%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 25 5,000 0.0%
UBS Group AG 9 1,909 0.0%
Founders Capital Management 8 1,667 0.0%
Connective Capital Management, LLC 5 1,016 0.0%